View Single Post
  #44  
Old 03-13-2022, 04:07 PM
irv's Avatar
irv irv is offline
D@le Irv*n
Member
 
Join Date: Jan 2016
Location: Ontario, Canada.
Posts: 6,696
Default

Like I mentioned above,,,as a "pre-covid" measure.

Another Pubmed study that clearly shows there is something there using ivermectin as a preventative measure, like one taking their vitamins bi-weekly or daily.

Ivermectin, as I also said above, is cheap. Is it any wonder why, because "they" cared about our health and well being so much, it wasn't suggested as a pre-covid preventative medicine/measure?

"Our study aimed to describe SARS-CoV2 infection and death rates in African countries that participated in an intensive Ivermectin mass campaign carried out to control onchocerciasis and compare them with those of countries that did not participate"

"Results: After controlling for different factors, including the Human Development Index (HDI), APOC countries (vs. non-APOC), show 28% lower mortality (0.72; 95% CI: 0.67-0.78) and 8% lower rate of infection (0.92; 95% CI: 0.91-0.93) due to COVID-19"


"Conclusions: The incidence in mortality rates and number of cases is significantly lower among the APOC countries compared to non-APOC countries. That a mass public health preventive campaign against COVID-19 may have taken place, inadvertently, in some African countries with massive community ivermectin use is an attractive hypothesis".
https://pubmed.ncbi.nlm.nih.gov/33795896/

Another study from the National Institute of Health.

Results and discussion
Our study compared the incidence of COVID-19 among countries with different PCT campaigns and those countries in which PCT is non-existent. It is perhaps obvious that the latter group is by far the largest. It should also not be surprising that this set of samples had a rather large variability (Fig. 1 ). However, in spite of this, the difference between nations that deploy PCT using ivermectin and those that do not use any PCT turned out to be highly significant (adjusted significance P < 0.01). These initial results were obtained on 15 April 2020 and because at that time SARS-CoV-2 was still being detected in new countries on an almost daily basis, we chose to monitor the situation and observe whether this correlation would over time become less significant. We updated our calculations and added additional newly affected countries several times throughout the month of May 2020 and noticed that the observed association between ivermectin MDA and lower COVID-19 incidence actually grew strictly stronger over time. By 5 June 2020, the adjusted significance had improved to P < 0.001, actually reported by IBM SPSS Statistics as 0.000. It has remained at that level since.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698683/

And another one.
https://www.medrxiv.org/content/10.1....26.21254377v1
"Conclusions The morbidity and mortality in the onchocerciasis endemic countries are lesser than those in the non-endemic ones. The community-directed onchocerciasis treatment with ivermectin is the most reasonable explanation for the decrease in morbidity and fatality rate in Africa. In areas where ivermectin is distributed to and used by the entire population, it leads to a significant reduction in mortality"

Last edited by irv; 03-13-2022 at 04:15 PM.
Reply With Quote